In particular, lymphoid enhancer-binding factor 1 (LEF1), Wnt/β-catenin pathway downstream effector, acts as a suppressor of necroptosis via the transcriptional suppression of CYLD in chronic lymphocytic leukemia [22]. The gene discussed is LEF1; the disease is B-cell chronic lymphocytic leukemia.